The vision for the National Phenome Centre is to harness the vast data generated by our cutting edge multi- technology platform to inform patient diagnosis and therapy, bringing data from the bench to the bedside. Leveraging research and maximising its potential impact.
Founded in 2012, co-funded by the MRC and the NIHR, The National Phenome Centre is a global leader in developing metabolic profiling techniques for advancing academic and clinical research in personalised medicine, diagnostics and nutrition.
Liver disease is the fifth commonest cause of death in the developed world. The global burden of liver cirrhosis is rising owing to an increased prevalence of alcohol and non-alcoholic-liver disease. Standardised mortality in...
Full case studyCongenital heart disease affects 1% of children and about 33% require surgery in early childhood. This surgery is challenging not only because of the young age of the patients but also because their abnormal circulatory physi...
Full case studyRT @IHepatology: Our @ImperialMDR and @CMBI_Imperial #GutMicrobiome #metabonome teams contributed to this great new study in @Micro_MDPI, l…
Go to tweetRT @HarryWhitwell7: Use one tool for peptide Mw, one for MZ, one for fragment Mz, one for modified peptides, one for fragment intensity pre…
Go to tweetRT @Imperial_PERC: It's not too late to be a #citizenscientist in the Crowd Forecasting Challenge which runs until 16 August! You can win £…
Go to tweet